Financial News
All News about Humanigen Inc
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Via NewMediaWire
Topics
Lawsuit
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_804.png?width=1200&height=800&fit=crop)
Humanigen, Inc. (NASDAQ:HGEN) Shareholder Notice: Lawsuit Alleges Misleading Statements
September 15, 2022
Via SBWire
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://mms.businesswire.com/media/20220907006191/en/805463/5/business_Wire_Robbins_LLP.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Via NewMediaWire
Topics
Lawsuit
![](https://mms.businesswire.com/media/20220902005005/en/779279/5/Screen_Shot_2020-03-10_at_10.22.21_AM.jpg)
![](https://mms.businesswire.com/media/20220830005913/en/805463/5/business_Wire_Robbins_LLP.jpg)
![](https://mms.businesswire.com/media/20220829005725/en/538768/5/BES_Mark.jpg)
![](https://mms.businesswire.com/media/20220829005700/en/805463/5/business_Wire_Robbins_LLP.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/08/30/image-bed_bath__beyond.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_15826.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/29/image42.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220829005558/en/1164042/5/July_30%2C_2021_-_ROSEN_LOGO.jpg)
![](https://mms.businesswire.com/media/20220829005528/en/827144/5/Schall-Firm-Logo-640x360.jpg)
![](https://investorplace.com/wp-content/uploads/2022/06/aapl-1600.png)
![](https://investorplace.com/wp-content/uploads/2019/11/pdd-stock-1.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/amc-1600-1-1024x576.png)
![](https://investorplace.com/wp-content/uploads/2021/06/vaccine-covid-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_15778.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/05/wall-street-morning.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/08/29/image29.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220827005007/en/827144/5/Schall-Firm-Logo-640x360.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Humanigen Reports Second Quarter 2022 Financial Results
August 12, 2022
From Humanigen, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.